Anlon Healthcare Limited (NSE:AHCL)

India flag India · Delayed Price · Currency is INR
13.20
-1.13 (-7.89%)
At close: Apr 28, 2026
43.48%
Market Cap 7.02B
Revenue (ttm) 1.70B
Net Income (ttm) 346.64M
Shares Out 531.52M
EPS (ttm) 0.78
PE Ratio 16.83
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 6,281,244
Average Volume 5,378,597
Open 14.20
Previous Close 14.33
Day's Range 12.91 - 14.20
52-Week Range 9.08 - 17.28
Beta n/a
RSI 51.86
Earnings Date Aug 21, 2026

About Anlon Healthcare

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumat... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 2013
Employees 117
Stock Exchange National Stock Exchange of India
Ticker Symbol AHCL
Full Company Profile

Financial Performance

In fiscal year 2025, Anlon Healthcare's revenue was 1.20 billion, an increase of 80.64% compared to the previous year's 666.16 million. Earnings were 205.18 million, an increase of 112.46%.

Financial Statements

News

There is no news available yet.